This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linscott, A. J.
Right arrow Articles by Bruckner, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linscott, A. J.
Right arrow Articles by Bruckner, D. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2004, p. 1365-1366, Vol. 42, No. 3
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.3.1365-1366.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Legionella pneumophila Serogroup 4 Isolated from Joint Tissue

Andrea J. Linscott,* Melinda D. Poulter, Kevin Ward, and David A. Bruckner

Department of Pathology and Laboratory Medicine, University of California, Los Angeles Medical Center, Los Angeles, California

Received 19 September 2003/ Returned for modification 30 October 2003/ Accepted 24 November 2003


arrow
ABSTRACT
 
We report the isolation of Legionella pneumophila serogroup 4 from synovial tissue obtained from an 80-year-old female with chronic swelling of her right metacarpophalangeal joint. Synovial tissue infections caused by L. pneumophila are rare. Interestingly, this isolate was recovered from chocolate agar after 5 days of incubation.


arrow
CASE REPORT
 
An 80-year-old female, initially seen for possible rheumatoid arthritis, presented with a recent seronegative inflammatory arthropathy characterized by pain and swelling in her fourth proximal interphalangeal (PIP) joint; this pain and swelling subsequently spread to other proximal interphalangeal joints. The patient was treated with cephalexin, which was discontinued after she developed hives, and then given prednisone at 40 mg per day for 5 days. She was referred to a rheumatologic consultant, who found evidence of underlying osteoarthritis of the hands, primarily involving the distal interphalangeal joints and the first carpal metacarpal phalangeal joints. The initial laboratory data for the patient were nondiagnostic in that she had a weakly positive antinuclear antibody test result, with a titer of 1:80 in serum without significant stigmata of lupus, and a negative test result for rheumatoid factor. A radiograph of the left hand showed osteoarthritis of the left metacarpal phalangeal (MCP) joint as well as the PIP joints. Three months later, the patient returned, having developed synovitis involving the right MCP and PIP joints, as well as pitting edema over the dorsal part of the right hand. She was later referred to UCLA Medical Center for synovectomy for both diagnostic and prognostic reasons.

Upon incision through the extensor tendon, an abundant amount of brownish synovium was noted, along with the absence of frank pus. The MCP joint was opened, and the presence of additional brownish synovium was documented. Some destruction of the articular cartilage within the joint was also noted. Joint tissue was sent for both aerobic and anaerobic cultures. No other laboratory tests were ordered at this time, and no antibiotic treatment was administered.

The joint tissue was processed according to standard operating procedures and inoculated onto sheep blood agar, chocolate agar supplemented with pyridoxal, and thioglycolate broth (BBL Microbiology Systems, Cockeysville, Md.) and incubated for 5 days at 37°C with 5 to 10% CO2. Additionally, brucella blood agar, laked kanamycin-vancomycin blood agar, anaerobic phenylethyl alcohol agar, and thioglycolate broth (BBL Microbiology Systems) were inoculated and incubated for 7 days at 37°C under anaerobic conditions. All anaerobic cultures were reported to be negative. Gram stains of the clinical specimen revealed no organisms or white blood cells.

On day 5, small, catalase-negative, oxidase-positive pinpoint colonies were noted on chocolate agar only. Buffered charcoal yeast extract agar was included as a medium for subculture to aid in the growth of this obviously fastidious organism. There was insufficient material from the original tissue specimen to inoculate buffered charcoal yeast extract agar for Legionella culture. The organism was subjected to serotyping with polyvalent conjugate containing fluorescein isothiocyanate-labeled antisera to Legionella pneumophila serogroups 1 through 6 (SciMedX Inc., Denville, N.J.), followed by testing against individual monovalent conjugates of types 1 through 6. The isolate was confirmed to be L. pneumophila serogroup 4 by the Los Angeles County Public Health Laboratory.

Hematoxylin and eosin stained sections of the right third joint synovial tissue indicated chronic synovitis with focal acute component and fibrin deposition. A Dieterle stain performed on the tissue section did not reveal any microorganisms.

Upon notification of the physician by the laboratory that L. pneumophila was recovered, the patient was directed to return to the clinic for further evaluation. The patient denied any history of pneumonia or traumatic injury to either hand. A complete blood count, urinalysis, two blood culture sets, and a Legionella urinary antigen were ordered. Laboratory results were as follows: white blood cell count, 6.4 x 103/mm3; red blood cell count, 3.55 x 106/mm3; total hemoglobin concentration, 11.9 g/dl; and hematocrit, 35.0%. An automated differential analysis revealed levels of 53.1% neutrophils, 34.6% lymphocytes, 8.9% monocytes, 2.7% eosinophils, and 0.7% basophils. Urinalysis results were within normal limits; the Legionella urinary antigen test result was negative, and blood cultures were negative for both sets. Chest films revealed no evidence of pneumonia. Although paired sera were not available for testing, a convalescent-phase serum was sent to an outside reference laboratory for the detection of L. pneumophila immunoglobulin G (IgG) antibody directed against serotypes 1 through 6 by use of an enzyme-linked immunoassay. An IgG value of 6.49 was obtained, indicating a current or previous infection with L. pneumophila (values of >1.10 are indicative of IgG antibody to L. pneumophila).

Our patient exhibited symptoms of pain, swelling, and a limited range of motion of the affected area, which could indicate rheumatoid arthritis, gout, or infectious arthritis. Radiograph analysis and surgical debridement of the hand showed cartilage destruction and osteoarthritis of the MCP and PIP joints. L. pneumophila serogroup 4 was isolated from the joint tissue.

Legionnaires' disease is the most common manifestation of infections caused by L. pneumophila (11, 16). Studies have shown that Legionnaires' disease occurs at a higher rate in persons with an altered immune system or rheumatoid arthritis or in association with drug therapy (3, 5, 15). The typical mode of transmission for L. pneumophila is inhalation of aerosols containing the organisms, which results in respiratory infection. Hematogenous spread is suspected as the primary source of infections for extrapulmonary infections. Extrapulmonary manifestations of L. pneumophila infection are rare in the absence of overt pulmonary infection. Most of these extrapulmonary infections have been associated with direct inoculation of the organism into a wound site during bathing, contact with a colonized water source, or the use of potting soil (4, 14, 19). Examples of extrapulmonary infections associated with L. pneumophila have included hip and sternal wound infections, prosthetic valve endocarditis, pyelonephritis, sinusitis, and cellulitis (4, 6, 7, 14, 18, 22). Soft tissue infections caused by Legionella cincinnatiensis and Legionella micdadei have been reported (12, 13), and L. micdadei has been reported to cause cutaneous abscesses in an immunosuppressed patient (1). The first reportable case of L. pneumophila arthritis involved a serogroup 1 organism recovered from an articular fluid specimen (2).

In the first case of infection with L. pneumophila serogroup 4, identified in Los Angeles in 1978, the organism was recovered from a chocolate agar plate after 7 days of incubation (10). Our L. pneumophila serogroup 4 isolate was also recovered from chocolate agar. Numerous reports in the literature describe selective, supplemented media available for the cultivation of Legionella species, but accounts of growth on routinely utilized, enriched media such as chocolate agar are rare (9, 17, 20, 21). As a result, the frequency at which this organism has been recovered from chocolate agar with or without pyridoxal supplementation is not known. Dumoff (8) discusses the recovery of L. pneumophila from a pleural fluid specimen and a lung tissue specimen on commercially available chocolate agar at 4 days and 9 days, respectively. Over the last several years, our institution has seen two other instances in which L. pneumophila serogroups 1 and 4 were recovered from respiratory specimens inoculated onto chocolate agar with pyridoxal (unpublished data).

Although the Legionella urinary antigen test can be used to support a diagnosis of legionellosis, it is important to remember that this assay is designed to detect only serogroup 1 and returns negative results for other serogroups.

The request for microbiological cultures in addition to radiology and pathology studies was an important feature of this case. Oftentimes, an infectious etiology is not considered in cases of suspected gout, osteoarthritis, or rheumatoid arthritis. This case also illustrates the importance of maintaining cultures of tissue or surgical specimens for a minimum of 5 days to detect the growth of fastidious organisms. Diagnosis of infectious arthritis can be readily achieved by microbiological, histological, and/or molecular methods.

We acknowledge Robert I. Morris (RDL Reference Laboratory, Santa Monica, Calif.) for providing a summary of the rheumatology findings.


arrow
FOOTNOTES
 
* Corresponding author. Present address: Louisiana State University Health Sciences Center, Department of Pathology, 1501 Kings Highway, Shreveport, LA 71130. Phone (318) 675-8682. Fax: (318) 675-7662. alinsc{at}lsuhsc.edu. Back


arrow
REFERENCES
 
    1
  1. Ampel, N. M., F. L. Ruben, and C. W. Norden. 1985. Cutaneous abscess caused by Legionella micdadei in an immunosuppressed patient. Ann. Intern. Med. 102:630-632.
    2. 2
  2. Bemer, P., S. Leautez, E. Ninn, S. Jarraud, F. Raffi, and H. Drugeon. 2002. Legionella pneumophila arthritis: use of medium specific for mycobacteria for isolation of L. pneumophila in culture for articular fluid specimens. Clin. Infect. Dis. 35:E6-E7.[CrossRef][Medline]
    3. 3
  3. Blatt, S. P., M. J. Dolan, C. W. Hendrix, and G. P. Melcher. 1994. Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review. Clin. Infect. Dis. 18:227-232.[Medline]
    4. 4
  4. Brabender, W., D. R. Hinthorn, M. Asher, N. J. Lindsey, and C. Liu. 1983. Legionella pneumophila wound infection. JAMA 250:3091-3092.[Abstract/Free Full Text]
    5. 5
  5. Chang, C. C., C. L. Chung, C. L. Huang, and F. C. Wang. 2001. Legionnaires' disease in a patient with rheumatoid arthritis. J. Microbiol. Immunol. Infect. 34:76-78.[Medline]
    6. 6
  6. Chen, T. T., J. M. Schapiro, and J. Loutit. 1996. Prosthetic valve endocarditis due to Legionella pneumophila. J. Cardiovasc. Surg. 67:631-633.
    7. 7
  7. Dorman, S. A., N. J. Hardin, and W. C. Winn. 1980. Pyelonephritis associated with Legionella pneumophila, serogroup 4. Ann. Intern. Med. 93:835-837.
    8. 8
  8. Dumoff, M. 1979. Direct in-vitro isolation of the Legionnaires' disease bacterium in two fatal cases. Cultural and staining characteristics. Ann. Intern. Med. 90:694-696.
    9. 9
  9. Edelstein, P. H., and M. A. C. Edelstein. 1991. Comparison of different agars used in the formulation of buffered charcoal yeast extract medium. J. Clin. Microbiol. 39:190-191.
    10. 10
  10. Edelstein, P. H., R. D. Meyer, and S. M. Finegold. 1978. Isolation of a new serotype of legionnaires' disease bacterium. Lancet ii:1172-1174.[CrossRef]
    11. 11
  11. Fraser, D. W., T. R. Tsai, W. Orenstein, W. E. Parkin, H. J. Beecham, R. G. Sharrar, J. Harris, G. F. Mallison, S. M. Martin, J. E. McDade, C. C. Shepard, and P. S. Brachman. 1977. Legionnaires' disease: description of an epidemic pneumonia. N. Engl. J. Med. 297:1189-1197.[Abstract]
    12. 12
  12. Gubler, J. G. H., M. Schorr, V. Gaia, R. Zbinden, and M. Altwegg. 2001. Recurrent soft tissue abscesses caused by Legionella cincinnatiensis. J. Clin. Microbiol. 39:4568-4570.[Abstract/Free Full Text]
    13. 13
  13. Kilborn, J. A., L. A. Manz, M. O'Brien, M. C. Douglass, H. M. Horst, W. Kupin, and E. J. Fisher. 1992. Necrotizing cellulitis caused by Legionella micdadei. JAMA 92:104-106.
    14. 14
  14. Lowry, P. W., R. J. Blankenship, W. Gridley, N. J. Troup, and L. S. Tompkins. 1991. A cluster of Legionella sternal wound infections due to postoperative topical exposure to contaminated tap water. N. Engl. J. Med. 324:109-113.[Medline]
    15. 15
  15. Marston, B. J., H. B. Lipman, and R. F. Breiman. 1994. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch. Intern. Med. 154:2417-2422.[Abstract/Free Full Text]
    16. 16
  16. McDade, J. E., C. C. Shepard, D. W. Fraser, T. R. Tsai, M. A. Redus, and W. R. Dowdle. 1977. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N. Engl. J. Med. 297:1197-1203.[Abstract]
    17. 17
  17. Ristroph, J. D., K. W. Hedlund, and S. Gowda. 1981. Chemically defined medium for Legionella pneumophila growth. J. Clin. Microbiol. 13:115-119.[Abstract/Free Full Text]
    18. 18
  18. Schlanger, G., L. I. Lutwick, M. Kurzman, B. Hoch, and F. W. Chandler. 1984. Sinusitis caused by Legionella pneumophila in a patient with the acquired immune deficiency syndrome. Am. J. Med. 77:957-960.[CrossRef][Medline]
    19. 19
  19. Steele, T. W., J. Lanser, and N. Sangster. 1990. Isolation of Legionella longbeachae serogroup 1 from potting mixes. Appl. Environ. Microbiol. 56:49-53.[Abstract/Free Full Text]
    20. 20
  20. Tesh, M. J., and R. D. Miller. 1981. Amino acid requirements for Legionella pneumophila growth. J. Clin. Microbiol. 13:865-869.[Abstract/Free Full Text]
    21. 21
  21. Tesh, M. J., and R. D. Miller. 1982. Growth of Legionella pneumophila in defined media: requirement for magnesium and potassium. Can. J. Microbiol. 28:1055-1058.[Medline]
    22. 22
  22. Waldor, M. K., B. Wilson, and M. Swartz. 1993. Cellulitis caused by Legionella pneumophila. Clin. Infect. Dis. 16:51-53.[Medline]

Journal of Clinical Microbiology, March 2004, p. 1365-1366, Vol. 42, No. 3
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.3.1365-1366.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linscott, A. J.
Right arrow Articles by Bruckner, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linscott, A. J.
Right arrow Articles by Bruckner, D. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»